Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Nanobiotechnology"
DOI: 10.1186/s12951-018-0356-z
Abstract: BackgroundMemantine, drug approved for moderate to severe Alzheimer’s disease, has not shown to be fully effective. In order to solve this issue, polylactic-co-glycolic (PLGA) nanoparticles could be a suitable solution to increase drug’s action on… read more here.
Keywords: drug; alzheimer disease; peg plga; mem peg ... See more keywords